Concepedia

Thomas Herzmann

TH

Statistics

Publications

2

Citations

85

H-Index

2

Active since

2000

Affiliations

Protalix BioTherapeutics (Israel)(Current)

University of Cologne

Thomas Herzmann is an author at Protalix BioTherapeutics (Israel) specializing in cell signaling, autoimmunity, and atherosclerosis.

ORCID

Top concepts

Publications per year

2000–2001

2

Publications

2

Caspase‐1‐inhibitor ac‐YVAD‐cmk reduces LPS‐lethality in rats without affecting haematology or cytokine responses

Guenther Mathiak, Guido Grass, Thomas Herzmann et al. · British Journal of Pharmacology · 2000 · 66 citations · Full text

, , +20

CHEMOKINES AND INTERLEUKIN-18 ARE UP-REGULATED IN BRONCHOALVEOLAR LAVAGE FLUID BUT NOT IN SERUM OF SEPTIC SURGICAL ICU PATIENTS

Guenther Mathiak, Lewis F. Neville, Guido Grass et al. · Shock · 2001 · 19 citations

1–2 of 2